Process Development for the Expansion of Equine Cord Blood Mesenchymal Stem Cells in Stirred Suspension Bioreactors for the Treatment of Joint Injuries in Horses

Simple item page
dc.contributor.advisorKallos, Michael S.
dc.contributor.authorRoberts, Erin L.
dc.contributor.committeememberHart, David A.
dc.contributor.committeememberDe La Hoz Siegler, H.
dc.date2018-06
dc.date.accessioned2018-05-08T17:47:56Z
dc.date.available2018-05-08T17:47:56Z
dc.date.issued2018-04-30
dc.description.abstractMusculoskeletal injuries are the leading cause of lameness and loss of performance in horses with conventional treatments having high rates of re-injury. Equine Mesenchymal stem cells (eMSCs), specifically equine cord blood derived MSCs (eCB-MSCs) are a promising treatment alternative owing to their ability to differentiate into cartilage, as well as due to their immunomodulating properties. However, treatments can require cell numbers in the millions or billions, therefore conventional expansion methods using static T-flasks are typically inadequate in achieving these cell numbers. Expansion of eCB-MSCs in stirred suspension bioreactors with microcarriers as an attachment surface has the potential to obtain a clinically relevant number of cells while decreasing cost, time and labour requirements and increasing reproducibility and yield when compared to static expansion. As eCB-MSCs had not yet been expanded in stirred suspension bioreactors, a robust protocol was required to expand these cells using this method. This study outlines the process development of expansion, detailing the inoculation phase, the expansion phase, and the harvesting phase, followed by further testing on different donor cells. The process achieved maximum cell densities up to 75,000 cells/cm2 corresponding to 40 million cells in a 100mL bioreactor, with a harvesting efficiency of up to 80%, corresponding to a yield of 32 million cells in a 100mL bioreactor. Further testing is required to ensure eCB-MSCs maintained phenotype and functionality, however this study lays the groundwork for the large scale bioprocess of the expansion of eCB-MSCs.en_US
dc.identifier.citationRoberts, E. L. (2018). Process Development for the Expansion of Equine Cord Blood Mesenchymal Stem Cells in Stirred Suspension Bioreactors for the Treatment of Joint Injuries in Horses (Master's thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca. doi:10.11575/PRISM/31900en_US
dc.identifier.doihttp://dx.doi.org/10.11575/PRISM/31900
dc.identifier.urihttp://hdl.handle.net/1880/106618
dc.language.isoeng
dc.publisher.facultyGraduate Studies
dc.publisher.facultySchulich School of Engineering
dc.publisher.institutionUniversity of Calgaryen
dc.publisher.placeCalgaryen
dc.rightsUniversity of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.
dc.subjectStem Cells
dc.subjectBioreactors
dc.subjectRegenerative Medicine
dc.subject.classificationBiology--Cellen_US
dc.subject.classificationEngineering--Biomedicalen_US
dc.titleProcess Development for the Expansion of Equine Cord Blood Mesenchymal Stem Cells in Stirred Suspension Bioreactors for the Treatment of Joint Injuries in Horses
dc.typemaster thesis
thesis.degree.disciplineBiomedical Engineering
thesis.degree.grantorUniversity of Calgary
thesis.degree.nameMaster of Science (MSc)
ucalgary.item.requestcopytrue
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ucalgary_2018_roberts_erin.pdf
Size:
5.85 MB
Format:
Adobe Portable Document Format
Description:
Master's Thesis
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.74 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Theses and Dissertations